Stay updated on Efficacy and Safety of MV130 in COPD Clinical Trial
Sign up to get notified when there's something new on the Efficacy and Safety of MV130 in COPD Clinical Trial page.

Latest updates to the Efficacy and Safety of MV130 in COPD Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page shows a minor revision label update (from v3.3.1 to v3.3.2) with no changes to study content or data. No core content, eligibility criteria, endpoints, or location details were modified. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1.SummaryDifference0.0%

- Check29 days agoChange DetectedRemoved the site-wide notice about funding status, while the MV130 COPD trial details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check43 days agoChange DetectedAdministrative metadata (results posting date and last update) was updated, while the core study content remains unchanged.SummaryDifference0.4%

- Check71 days agoChange DetectedSummary of changes: the page now presents updated trial details for MV130 in COPD, including design, endpoints, dosing, eligibility, sites, and current/expected results posting timelines, replacing older status language.SummaryDifference100%

- Check79 days agoChange Detected- Added revision label v3.1.0. - Removed several drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and an earlier version note (Revision: v3.0.2).SummaryDifference0.6%

Stay in the know with updates to Efficacy and Safety of MV130 in COPD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy and Safety of MV130 in COPD Clinical Trial page.